Table 1 Characteristics of the study cohort, stratified by the index date relative to RACF entry
Characteristic | Index date in the 0 to 3Â months after RACF entry | Index date in the 3 to 6Â months after RACF entry | Index date in the 6 to 12Â months after RACF entry | |||
|---|---|---|---|---|---|---|
Received RMMR (n = 23979) | No RMMR (n = 55609) | Received RMMR (n = 19080) | No RMMR (n = 49468) | Received RMMR (n = 11962) | No RMMR (n = 42573) | |
Number of RACFs | 1772 | 1959 | 1809 | 1949 | 1770 | 1925 |
Age (years) at RACF entry, median (IQR) | 85.0 (80.0–89.0) | 85.0 (80.0–89.0) | 85.0 (80.0–89.0) | 85.0 (80.0–89.0) | 84.0 (79.0–89.0) | 85.0 (80.0–89.0) |
Female, n (%) | 15367 (64.1) | 35233 (63.4) | 12403 (65.0) | 32143 (65.0) | 7938 (66.4) | 28324 (66.5) |
Born in Australia, n (%)a | 14798 (62.0) | 36452 (65.8) | 12358 (65.0) | 32358 (65.7) | 7911 (66.5) | 27803 (65.6) |
Primary language other than English, n (%)b | 3571 (14.9) | 7014 (12.6) | 2447 (12.8) | 6296 (12.7) | 1401 (11.7) | 5461 (12.8) |
RACF provider type, n (%) | Â | Â | Â | Â | Â | Â |
  For profit | 10368 (43.2) | 23373 (42.0) | 8086 (42.4) | 20525 (41.5) | 4986 (41.7) | 17407 (40.9) |
  Government | 1166 (4.9) | 3228 (5.8) | 923 (4.8) | 2743 (5.5) | 710 (5.9) | 2265 (5.3) |
  Not for profit | 12445 (51.9) | 29008 (52.2) | 10071 (52.8) | 26200 (53.0) | 6266 (52.4) | 22901 (53.8) |
Remoteness of residencec, n (%) | ||||||
  Major Cities | 18476 (77.1) | 38172 (68.6) | 13551 (71.0) | 34092 (68.9) | 8021 (67.1) | 29463 (69.2) |
  Outside Major Cities | 5503 (22.9) | 17437 (31.4) | 5529 (29.0) | 15376 (31.1) | 3941 (32.9) | 13110 (30.8) |
State of residence, n (%) | Â | Â | Â | Â | Â | Â |
  New South Wales | 10963 (45.7) | 26184 (47.1) | 8957 (46.9) | 23160 (46.8) | 5225 (43.7) | 19885 (46.7) |
  South Australia | 2801 (11.7) | 9028 (16.2) | 2082 (10.9) | 8102 (16.4) | 1596 (13.3) | 7065 (16.6) |
  Victoria | 10215 (42.6) | 20397 (36.7) | 8041 (42.1) | 18206 (36.8) | 5141 (43.0) | 15623 (36.7) |
No. of unique prescriptions dispensed in the year before RACF entry, median (IQR) | 11.0 (7.0–15.0) | 11.0 (7.0–15.0) | 11.0 (7.0–15.0) | 11.0 (7.0–15.0) | 11.0 (7.0–15.0) | 11.0 (7.0–15.0) |
Rx-risk comorbidity scored, median (IQR) | 5.0 (3.0–7.0) | 5.0 (3.0–7.0) | 5.0 (3.0–7.0) | 5.0 (3.0–7.0) | 5.0 (3.0–7.0) | 5.0 (3.0–7.0) |
Dementiae, n (%) | 12457 (51.9) | 27534 (49.5) | 9540 (50.0) | 24719 (50.0) | 5869 (49.1) | 21344 (50.1) |
Assisted Daily Living levelf, n (%) | ||||||
  Nil | 308 (1.3) | 1028 (1.8) | 365 (1.9) | 987 (2.0) | 243 (2.0) | 920 (2.2) |
  Low | 6517 (27.2) | 15613 (28.1) | 5741 (30.1) | 14697 (29.7) | 3924 (32.8) | 13301 (31.2) |
  Medium | 8042 (33.5) | 18841 (33.9) | 6478 (34.0) | 16997 (34.4) | 4041 (33.8) | 14722 (34.6) |
  High | 9112 (38.0) | 20127 (36.2) | 6496 (34.0) | 16787 (33.9) | 3754 (31.4) | 13630 (32.0) |
Behavioral Daily Living levelf, n (%) | ||||||
  Nil | 1967 (8.2) | 5416 (9.7) | 1739 (9.1) | 4981 (10.1) | 1262 (10.6) | 4426 (10.4) |
  Low | 5498 (22.9) | 13249 (23.8) | 4660 (24.4) | 12142 (24.5) | 3071 (25.7) | 10716 (25.2) |
  Medium | 6297 (26.3) | 14571 (26.2) | 4968 (26.0) | 12853 (26.0) | 3109 (26.0) | 11027 (25.9) |
  High | 10217 (42.6) | 22373 (40.2) | 7713 (40.4) | 19492 (39.4) | 4520 (37.8) | 16404 (38.5) |
Complex Health Care levelf, n (%) | ||||||
  Nil | 1639 (6.8) | 4582 (8.2) | 1509 (7.9) | 4314 (8.7) | 1065 (8.9) | 3955 (9.3) |
  Low | 7156 (29.8) | 16782 (30.2) | 6036 (31.6) | 15470 (31.3) | 3947 (33.0) | 13671 (32.1) |
  Medium | 6255 (26.1) | 14994 (27.0) | 5066 (26.6) | 13507 (27.3) | 3236 (27.1) | 11665 (27.4) |
  High | 8929 (37.2) | 19251 (34.6) | 6469 (33.9) | 16177 (32.7) | 3714 (31.0) | 13282 (31.2) |
Residents remaining in the cohort at the end of 4-month follow-up, n (%) | 19253 (80.3) | 42398 (76.2) | 15741 (82.5) | 40212 (81.3) | 9652 (80.7) | 34576 (81.2) |